Efficacy of Anifrolumab Treatment in Improving Joint Outcomes: Pooled Data from Intravenous and Subcutaneous Phase 3 Trials (ACR Convergence 2026) - Sep 8, 2026 - Abstract #2201; Pres time: Nov 10, 2026; 10:30 AM - 12:30 PM; Location: WB1&2; In Person; No abstract available
Clinical • P3 data • Immunology • Lupus • Systemic Lupus Erythematosus
|